VRK1 and neoplasm: VRK1 depletion also impairs the accumulation of H4K20m2 [39], similar to KMT inhibitors [40], which is necessary for the recruitment of 53BP1 in the non-homologous end joining (NHEJ) DNA damage repair pathway [169,170], thus sensitizing tumor cells to genotoxic treatments.